# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
On August 14, 2025, Xos, Inc. (the "Company") entered into a Sales Agreement (the "Sales Agreement") with Roth ...
Wedbush analyst Daniel Ives maintains Xos (NASDAQ:XOS) with a Outperform and raises the price target from $6 to $7.
https://www.sec.gov/Archives/edgar/data/1819493/000121390025076164/ea0252793-01.htm
Xos (NASDAQ:XOS) affirms FY2025 sales outlook from $50.200 million-$65.800 million to $50.200 million-$65.800 million vs $56.21...